Delivering Enhanced
Topical Products
Sol-Gel develops innovative specialty pharmaceuticals for the dermatology market. With state-of-the-art, patented delivery systems, Sol-Gel strives to improve the efficacy, tolerability and safety of topical drugs.
Innovative dermatological drug products that demonstrate significantly improved efficacy and tolerability profiles
Innovative topical drugs including first-in-class non-antibiotic topical drug SGT-VD-54 for treatment of rosacea that has met endpoint Phase II trials
  Terms of Use    |  Copyright Policy   |  Contact Us